Drägerwerk AG & Co. KGaA: Preliminary figures for the first quarter of 2022 - Increasing difficulties in the supply of electronic components make the lower end of the full-year guidance likely
Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Forecast
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Dräger releases preliminary figures for the first quarter of 2022 - Increasing difficulties in the supply of electronic components make the lower end of the full-year guidance likely
Order intake developed positively. Adjusted for currency effects, it increased by 10.2 percent to EUR 825.7 million (Q1 2021: EUR 739.8 million) in the first quarter of 2022, growing both in the Medical and Safety divisions.
Business performance in the first quarter is therefore in line with the previously published guidance, which expects a currency-adjusted decline in net sales of between -5.0 and -9.0 percent and an EBIT margin of between 1.0 and 4.0 percent for the current year. The Executive Board confirms the guidance, but now considers the lower end likely due to the increasing difficulties in the supply of electronic components.
The full results for the first three months of the fiscal year will be published on April 28, 2022.
Drägerwerk AG & Co. KGaA
13-Apr-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||Drägerwerk AG & Co. KGaA|
|Moislinger Allee 53-55|
|Phone:||+49 (0)451 882-0|
|Fax:||+49 (0)451 882-2080|
|ISIN:||DE0005550602, DE 000 555 063 6, DE 000 555 071 9|
|WKN:||555060, 555063 Vorzüge, 555071 Genussschein D|
|Listed:||Regulated Market in Berlin, Frankfurt (Prime Standard), Hamburg, Hanover; Regulated Unofficial Market in Stuttgart, Tradegate Exchange|
|EQS News ID:||1327855|
|End of Announcement||DGAP News Service|